Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Express Scripts
McKesson
Baxter
US Department of Justice
Accenture
Citi
Queensland Health
Fuji

Generated: December 10, 2017

DrugPatentWatch Database Preview

IMODIUM Drug Profile

« Back to Dashboard

Which patents cover Imodium, and when can generic versions of Imodium launch?

Imodium is a drug marketed by J And J Consumer Inc and Janssen Pharms and is included in eight NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in IMODIUM is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
J And J Consumer IncIMODIUMloperamide hydrochlorideCAPSULE;ORAL017690-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
J And J Consumer IncIMODIUM A-D EZ CHEWSloperamide hydrochlorideTABLET, CHEWABLE;ORAL020448-001Jul 24, 1997DISCNYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
J And J Consumer IncIMODIUM A-Dloperamide hydrochlorideSOLUTION;ORAL019487-001Mar 1, 1988OTCYesYes► Subscribe► Subscribe► Subscribe► Subscribe
J And J Consumer IncIMODIUM MULTI-SYMPTOM RELIEFloperamide hydrochloride; simethiconeTABLET, CHEWABLE;ORAL020606-001Jun 26, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
J And J Consumer IncIMODIUMloperamide hydrochlorideCAPSULE;ORAL017694-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Janssen PharmsIMODIUMloperamide hydrochlorideSOLUTION;ORAL019037-001Jul 31, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
J And J Consumer IncIMODIUM A-Dloperamide hydrochlorideTABLET;ORAL019860-001Nov 22, 1989OTCYesYes► Subscribe► Subscribe► Subscribe► Subscribe
J And J Consumer IncIMODIUM A-Dloperamide hydrochlorideSUSPENSION;ORAL019487-002Jul 8, 2004OTCYesYes► Subscribe► Subscribe► Subscribe► Subscribe
J And J Consumer IncIMODIUM MULTI-SYMPTOM RELIEFloperamide hydrochloride; simethiconeTABLET;ORAL021140-001Nov 30, 2000OTCYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: IMODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer IncIMODIUMloperamide hydrochlorideCAPSULE;ORAL017694-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Janssen PharmsIMODIUMloperamide hydrochlorideSOLUTION;ORAL019037-001Jul 31, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for IMODIUM

Drugname Dosage Strength RLD Submissiondate
loperamide hydrochloride and simethiconeTablets2 mg/125 mgImodium Advanced12/29/2004

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Harvard Business School
Express Scripts
Citi
Julphar
Deloitte
Colorcon
McKesson
Merck
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot